Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

  • PerkinElmer, Sangmyung Partner
Mar 2009
PerkinElmer of Waltham, Mass., has entered into a drug discovery research collaboration with Sangmyung University in the Republic of Korea, based on applying the American company’s AequoScreen aequorin assay technology to G-protein coupled receptor (GPCR) research. It is estimated that GPCRs are associated with at least 30 percent of addressable diseases and continue to be a key focus in drug discovery. Aequorin assays are a cell-based assay technology used to detect GPCR activation. Their advantages over conventional fluorescence-based dyes include fewer false positives, simpler protocol and increased assay windows. AequoScreen will be used by the university as part of its efforts to establish an academic GPCR screening facility in conjunction with the Korea Chemical Bank, a national repository library of more than 100,000 small-molecule compounds. The aequorin technology will be used as part of nationwide GPCR screening campaigns and drug discovery programs in South Korea.

The technology of generating and harnessing light and other forms of radiant energy whose quantum unit is the photon. The science includes light emission, transmission, deflection, amplification and detection by optical components and instruments, lasers and other light sources, fiber optics, electro-optical instrumentation, related hardware and electronics, and sophisticated systems. The range of applications of photonics extends from energy generation to detection to communications and...
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x We deliver – right to your inbox. Subscribe FREE to our newsletters.